-
Mashup Score: 1Pharmacoepidemiology and Drug Safety Call for Papers Evaluating the Impact of Regulatory Decisions using Real-World Evidence - 7 month(s) ago
Submission deadline: Thursday, 1 February 2024 Medicinal products are rigorously assessed by regulators before these are authorized for use in populations. As not all aspects of their safety is known at market approval, pharmacovigilance systems have been put in place to safeguard a positive benefit-risk balance during their lifecycle. When new safety concerns are discovered, regulators can implement risk minimization measures in order to maintain a positive benefit-risk balance. These measures usually
Source: onlinelibrary.wiley.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
In a nested case-control study, Yu-Jung Jenny Wei and colleagues study associations between injury following prescription opioid initiation and risk of an opioid-related adverse event among older Medicare beneficiaries in the US.
Source: journals.plos.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Yu-Jung Jenny Wei and colleagues study associations between injury following prescription opioid initiation and risk of an opioid-related adverse event among older Medicare beneficiaries in the US. https://t.co/9Iv6TW1zk7 #medicine #pharmacoepidemiology #aging #research https://t.co/aowXay7ZmI
-
-
Mashup Score: 0Pharmacoepidemiology and Drug Safety - 2 year(s) ago
Call for Papers Pharmacoepidemiology and Drug Safety will be publishing a Special Issue themed around Pharmacoepidemiology Science Communication Editor: Vincent Lo Re III Papers of particular interest might include studies that examine: Preferences for communication of pharmacoepidemiologic measures, results (e.g., preferred type of…
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#Pharmacoepidemiology & Drug Safety is inviting papers for a Special Issue (or Section) in 2022 focused on the topics: ➡️ Pharmacoepidemiology Science Communication ➡️ Diversity, Equity, and Inclusion Learn more now: https://t.co/oUZgZnYkYW @IntPharmacoEpi https://t.co/eN3b5oDZrR
-
-
Mashup Score: 0
Click on the article title to read more.
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Interested in #Pharmacoepidemiology? Check out the 30 must-read papers for newcomers suggested by @Pottegard @lucasmorin_eolc Jesper Hallas, Tobias Gerhard, @AlmutWinterste1 @Gutthann & @Mina__T in Pharmacoepidemiology & Drug Safety: https://t.co/GIKBYKJsnm @IntPharmacoEpi https://t.co/3G6t5yO65m
-
-
Mashup Score: 0Pharmacoepidemiology and Drug Safety - 2 year(s) ago
Call for Papers Pharmacoepidemiology and Drug Safety will be publishing a Special Issue themed around Pharmacoepidemiology Science Communication Editor: Vincent Lo Re III Papers of particular interest might include studies that examine: Preferences for communication of pharmacoepidemiologic measures, results (e.g., preferred type of…
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#Pharmacoepidemiology & Drug Safety is inviting papers for a Special Issue (or Section) in 2022 focused on the topics: ➡️ Pharmacoepidemiology Science Communication ➡️ Diversity, Equity, and Inclusion Learn more now: https://t.co/NCfYCbyzln @IntPharmacoEpi https://t.co/WmLOzb0eLF
-
-
Mashup Score: 2
Click on the article title to read more.
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Interested in #Pharmacoepidemiology? Check out the 30 must-read papers for newcomers suggested by @Pottegard @lucasmorin_eolc Jesper Hallas, Tobias Gerhard, @AlmutWinterste1 @Gutthann & @Mina__T in Pharmacoepidemiology & Drug Safety: https://t.co/GIKBYKJsnm @IntPharmacoEpi https://t.co/2WhuMc1QyD
-
-
Mashup Score: 0Pharmacoepidemiology and Drug Safety - 2 year(s) ago
Call for Papers Pharmacoepidemiology and Drug Safety will be publishing a Special Issue themed around Pharmacoepidemiology Science Communication Editor: Vincent Lo Re III Papers of particular interest might include studies that examine: Preferences for communication of pharmacoepidemiologic measures, results (e.g., preferred type of…
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#Pharmacoepidemiology & Drug Safety is inviting papers for a Special Issue (or Section) in 2022 focused on the topics: ➡️ Pharmacoepidemiology Science Communication ➡️ Diversity, Equity, and Inclusion Learn more now: https://t.co/VUmRewuPxQ @IntPharmacoEpi https://t.co/fJje6pGEUt
-
Call for papers! Submit your work to #Pharmacoepidemiology & Drug Safety for a special issue on evaluating the impact of regulatory decisions using real-world evidence. 📅 Submission deadline: February 1, 2024 Find out more now: https://t.co/LxRoagBMz4 https://t.co/ND7hL6IUp5